(2R)-2-Propan-2-ylcyclopentan-1-one | 1621700-18-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: (2R)-2-Propan-2-ylcyclopentan-1-one
• 英文别名: (2R)-2-propan-2-ylcyclopentan-1-one
• CAS: 1621700-18-2
• 化学式: C₈H₁₄O
• 分子量: 126.199
• InChiKey: RKZBBVUTJFJAJR-SSDOTTSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-甲基-1,3-二氧戊环-2-丙酸乙酯 、 (2R)-2-Propan-2-ylcyclopentan-1-one 在 sodium ethanolate 、 盐酸 、 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 26.0h， 生成 (1R)-1-propan-2-yl-1,2,3,3a,5,6-hexahydroazulene-4,7-dione
  参考文献：
  名称：

  Synthesis, activity and mechanism for double-ring conjugated enones

  摘要：

  DOI：

  10.1016/j.bmcl.2021.128315

文献信息

• PYRIDINES AND PYRIMIDINES AND USE THEREOF
  申请人：Purdue Pharma L.P.

  公开号：US20170008882A1

  公开（公告）日：2017-01-12

  The present disclosure provides pyridines and pyrimidines of Formula I and pharmaceutically acceptable salts and solvates thereof: wherein A, G, W 1 , W 2 , W 3 , and R 5 are defined as set forth in the specification. The present disclosure also provides uses of the compounds of Formula I and pharmaceutically acceptable salts and solvates thereof. In certain embodiments, Compounds of the present disclosure are useful for treating pain. In another embodiment, Compounds of the present disclosure are useful for treating a disorder responsive to blockade of sodium channels, or alleviating symptoms of the disorder.

  本公开提供了Formula I的吡啶和嘧啶以及其药用可接受的盐和溶剂化合物：其中A、G、W1、W2、W3和R5如规范中所述。本公开还提供了Formula I化合物及其药用可接受的盐和溶剂的用途。在某些实施例中，本公开的化合物对治疗疼痛有用。在另一实施例中，本公开的化合物对治疗对钠通道阻滞有反应的疾病，或缓解该疾病的症状有用。
• [EN] SYNTHETIC LIGANDS THAT MODULATE THE ACTIVITY OF THE RHLR QUORUM SENSING RECEPTOR<br/>[FR] LIGANDS SYNTHÉTIQUES MODULANT L'ACTIVITÉ DU RÉCEPTEUR DE DÉTECTION DU QUORUM RHLR
  申请人：WISCONSIN ALUMNI RES FOUND

  公开号：WO2017190116A1

  公开（公告）日：2017-11-02

  RhlR modulators including agonist and antagonists which are useful for modulating QS phenotypes in Gram-negative bacteria. Certain compounds of general formula A-W-HG having various carbocyclic ad heterocyclic head groups (HG) and various tail groups (A), where -W- is -CO-NH-, -SO2-NH-, -CO-NH-CH2-, or -SO2-NH-CH2- are RhlR agonists or antagonists. The compounds are useful in methods of modulating quorum sensing in Gram-negative bacteria, particularly in Pseudomonas. Compositions including certain RhlR modulators are useful for decreasing the virulence of Gram-negative bacteria. Pharmaceutical compositions comprising certain RhlR modulators are useful for treatment of infections of Gram-negative bacteria.

  RhlR调节剂包括激动剂和拮抗剂，对调节革兰氏阴性细菌中的QS表型有用。具有一般公式A-W-HG的某些化合物具有各种碳环和杂环头基团（HG）和各种尾基团（A），其中-W-为-CO-NH-，-SO2-NH-，-CO-NH-CH2-或-SO2-NH- -是RhlR激动剂或拮抗剂。这些化合物在调节革兰氏阴性细菌中的群体感应方法中有用，特别是在铜绿假单胞菌中。包含某些RhlR调节剂的组合物有助于降低革兰氏阴性细菌的毒力。包含某些RhlR调节剂的药物组合物有助于治疗革兰氏阴性细菌感染。
• Carboxamide Derivatives and Use Thereof
  申请人：PURDUE PHARMA L.P.

  公开号：US20160031873A1

  公开（公告）日：2016-02-04

  The present disclosure provides substituted pyridyl-, pyrimidinyl-, pyrazinyl-, pyridazinyl-, and triazinyl-based carboxamides of Formula I-A: R 10 Z-HET-E I-A and the pharmaceutically acceptable salts and solvates thereof, wherein Z, HET, R 10 and E are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I-A to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.

  本公开提供了公式I-A的取代吡啶基、嘧啶基、吡嗪基、吡啉基和三嗪基羧酰胺，以及其药学上可接受的盐和溶剂化合物，其中Z、HET、R10和E如规范中所定义。本公开还涉及使用公式I-A的化合物治疗对钠通道阻滞有响应的疾病。本公开的化合物特别适用于治疗疼痛。
• Compound Combinations for Attenuation of Bacterial Virulence
  申请人：WISCONSIN ALUMNI RESEARCH FOUNDATION

  公开号：US20170231962A1

  公开（公告）日：2017-08-17

  Methods for modulating quorum sensing in certain Gram-negative bacteria having multiple QS systems including Las, Rhl, and Pqs with associated receptors (LasR, RhlR and PqsR) which are modulated by small molecule modulators, particularly non-native modulators. Certain combinations of modulators of Las, Rhl and Pqs exhibit improved inhibition of virulence in comparison to the respective individual modulators. In particular, certain combinations of modulators exhibit improved inhibition in nutritionally depleted environments. More specifically, certain combinations of modulators exhibit improved inhibition in environments depleted in phosphate and/or environments depleted in iron. Nutrient depleted environments can mimic environments associated with bacterial infection in humans and non-human animals. The methods are useful in particular for modulating QS in Pseudomonas and Buckholderia.

  在某些具有多个QS系统的革兰氏阴性细菌中，包括具有相关受体（LasR、RhlR和PqsR）的Las、Rhl和Pqs的调控方法，这些受体受小分子调节剂（尤其是非天然调节剂）的调节。Las、Rhl和Pqs的某些调节剂组合相比于各自的单个调节剂表现出对毒力的改善抑制。特别是，某些调节剂组合在营养匮乏环境中表现出改善的抑制作用。更具体地说，某些调节剂组合在缺乏磷酸盐和/或缺乏铁的环境中表现出改善的抑制作用。营养匮乏环境可以模拟与人类和非人类动物细菌感染相关的环境。这些方法特别适用于调节假单胞菌和布氏杆菌中的QS。
• PYRIMIDINE CARBOXAMIDES AS SODIUM CHANNEL BLOCKERS
  申请人：LOCKMAN Jeffrey

  公开号：US20160009659A1

  公开（公告）日：2016-01-14

  The present disclosure provides substituted pyrimidine carboxamides of Formula (I) and the pharmaceutically acceptable salts and solvates thereof, wherein A 1 , X, A 2 , W 1 , W 2 , W 3 , E, Z, and R 4 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of sodium channels. Compounds of the present disclosure are especially useful for treating pain.

  本公开提供了式(I)的取代嘧啶羧酰胺及其药学上可接受的盐和溶剂化物，其中A1、X、A2、W1、W2、W3、E、Z和R4如规范所述。本公开还针对使用式(I)的化合物治疗对钠通道阻滞有反应的疾病。本公开的化合物特别适用于治疗疼痛。